263 related articles for article (PubMed ID: 20232705)
21. The concentrations of bile acids and erythropoietin in pregnant women with intrahepatic cholestasis and the state of the fetus and newborn.
Kowalska-Kańka A; Maciejewski T; Niemiec KT
Med Wieku Rozwoj; 2013; 17(3):232-45. PubMed ID: 24296447
[TBL] [Abstract][Full Text] [Related]
22. Clinical grading of intrahepatic cholestasis pregnancy.
Pradhan M; Shao Y
JNMA J Nepal Med Assoc; 2013; 52(190):413-9. PubMed ID: 24362672
[TBL] [Abstract][Full Text] [Related]
23. Increased intercellular adhesion molecule-1 serum concentration in cholestasis.
Polzien F; Ramadori G
J Hepatol; 1996 Dec; 25(6):877-86. PubMed ID: 9007716
[TBL] [Abstract][Full Text] [Related]
24. Beneficial effect of ursodeoxycholic acid on alterations induced by cholestasis of pregnancy in bile acid transport across the human placenta.
Serrano MA; Brites D; Larena MG; Monte MJ; Bravo MP; Oliveira N; Marin JJ
J Hepatol; 1998 May; 28(5):829-39. PubMed ID: 9625319
[TBL] [Abstract][Full Text] [Related]
25. Intrahepatic cholestasis of pregnancy: correlation of preterm delivery with bile acids.
Pata O; Vardarelı E; Ozcan A; Serteser M; Unsal I; Saruç M; Unlü C; Tözün N
Turk J Gastroenterol; 2011 Dec; 22(6):602-5. PubMed ID: 22287405
[TBL] [Abstract][Full Text] [Related]
26. Corticotropin-releasing hormone expression in patients with intrahepatic cholestasis of pregnancy after ursodeoxycholic acid treatment: an initial experience.
Zhou F; Zhang L; He MM; Liu ZF; Gao BX; Wang XD
Curr Med Res Opin; 2014 Aug; 30(8):1529-35. PubMed ID: 24665980
[TBL] [Abstract][Full Text] [Related]
27. Ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy: a randomized controlled trial.
Joutsiniemi T; Timonen S; Leino R; Palo P; Ekblad U
Arch Gynecol Obstet; 2014 Mar; 289(3):541-7. PubMed ID: 23978872
[TBL] [Abstract][Full Text] [Related]
28. Rifampicin in the treatment of severe intrahepatic cholestasis of pregnancy.
Geenes V; Chambers J; Khurana R; Shemer EW; Sia W; Mandair D; Elias E; Marschall HU; Hague W; Williamson C
Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():59-63. PubMed ID: 25864112
[TBL] [Abstract][Full Text] [Related]
29. Bile acid patterns in meconium are influenced by cholestasis of pregnancy and not altered by ursodeoxycholic acid treatment.
Rodrigues CM; Marín JJ; Brites D
Gut; 1999 Sep; 45(3):446-52. PubMed ID: 10446117
[TBL] [Abstract][Full Text] [Related]
30. Ursodeoxycholic acid therapy in intrahepatic cholestasis of pregnancy: Results in real-world conditions and factors predictive of response to treatment.
Bacq Y; le Besco M; Lecuyer AI; Gendrot C; Potin J; Andres CR; Aubourg A
Dig Liver Dis; 2017 Jan; 49(1):63-69. PubMed ID: 27825922
[TBL] [Abstract][Full Text] [Related]
31. [Pay more attention to standardizing the diagnosis and treatment of intrahepatic cholestasis of pregnancy].
Liu XH; He J
Zhonghua Fu Chan Ke Za Zhi; 2011 May; 46(5):321-3. PubMed ID: 21733364
[No Abstract] [Full Text] [Related]
32. Intrahepatic cholestasis of pregnancy: changes in maternal-fetal bile acid balance and improvement by ursodeoxycholic acid.
Brites D
Ann Hepatol; 2002; 1(1):20-8. PubMed ID: 15114292
[TBL] [Abstract][Full Text] [Related]
33. Role of sphingolipids in the pathogenesis of intrahepatic cholestasis.
Mikucka-Niczyporuk A; Pierzynski P; Lemancewicz A; Kosinski P; Charkiewicz K; Knas M; Kacerovsky M; Blachnio-Zabielska A; Laudanski P
Prostaglandins Other Lipid Mediat; 2020 Apr; 147():106399. PubMed ID: 31733339
[TBL] [Abstract][Full Text] [Related]
34. Intrahepatic cholestasis of pregnancy: Amelioration of pruritus by UDCA is associated with decreased progesterone disulphates in urine.
Glantz A; Reilly SJ; Benthin L; Lammert F; Mattsson LA; Marschall HU
Hepatology; 2008 Feb; 47(2):544-51. PubMed ID: 17968976
[TBL] [Abstract][Full Text] [Related]
35. S-adenosylmethionine versus ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy: preliminary results of a controlled trial.
Floreani A; Paternoster D; Melis A; Grella PV
Eur J Obstet Gynecol Reprod Biol; 1996 Aug; 67(2):109-13. PubMed ID: 8841797
[TBL] [Abstract][Full Text] [Related]
36. Increased syndecan-1 and glypican-3 predict poor perinatal outcome and treatment resistance in intrahepatic cholestasis.
Gümüş Güler B; Özler S
Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):271-276. PubMed ID: 31919038
[TBL] [Abstract][Full Text] [Related]
37. Fetal death in a patient with intrahepatic cholestasis of pregnancy.
Sentilhes L; Verspyck E; Pia P; Marpeau L
Obstet Gynecol; 2006 Feb; 107(2 Pt 2):458-60. PubMed ID: 16449148
[TBL] [Abstract][Full Text] [Related]
38. [Intrahepatic cholestasis of pregnancy: a disorder of increased fetal risks. Part I. Maternal condition].
Jóźwik M; Jóźwik M; Bartnicki J; Jóźwik M
Ginekol Pol; 2007 Apr; 78(4):312-6. PubMed ID: 17621995
[TBL] [Abstract][Full Text] [Related]
39. Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy.
Binder T; Salaj P; Zima T; Vítek L
J Perinat Med; 2006; 34(5):383-91. PubMed ID: 16965225
[TBL] [Abstract][Full Text] [Related]
40. [Intrahepatic cholestasis of pregnancy: review].
Medina Lomelí JM; Jáuregui Meléndrez RA; Medina Castro N; Medina Castro D
Ginecol Obstet Mex; 2012 Apr; 80(4):285-94. PubMed ID: 22808859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]